Pacira Biosciences, Inc. (PCRX)
25.21
+0.35
(+1.41%)
USD |
NASDAQ |
Aug 25, 13:36
Pacira Biosciences Total Assets (Quarterly) : 1.244B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.244B |
| March 31, 2026 | 1.209B |
| December 31, 2025 | 1.265B |
| September 30, 2025 | 1.298B |
| June 30, 2025 | 1.537B |
| March 31, 2025 | 1.587B |
| December 31, 2024 | 1.554B |
| September 30, 2024 | 1.522B |
| June 30, 2024 | 1.647B |
| March 31, 2024 | 1.583B |
| December 31, 2023 | 1.574B |
| September 30, 2023 | 1.534B |
| June 30, 2023 | 1.542B |
| March 31, 2023 | 1.523B |
| December 31, 2022 | 1.681B |
| September 30, 2022 | 1.734B |
| June 30, 2022 | 1.734B |
| March 31, 2022 | 1.891B |
| December 31, 2021 | 2.075B |
| September 30, 2021 | 1.356B |
| June 30, 2021 | 1.326B |
| March 31, 2021 | 1.288B |
| December 31, 2020 | 1.275B |
| September 30, 2020 | 1.220B |
| June 30, 2020 | 866.11M |
| Date | Value |
|---|---|
| March 31, 2020 | 821.38M |
| December 31, 2019 | 831.06M |
| September 30, 2019 | 807.49M |
| June 30, 2019 | 787.84M |
| March 31, 2019 | 719.16M |
| December 31, 2018 | 689.35M |
| September 30, 2018 | 659.04M |
| June 30, 2018 | 642.68M |
| March 31, 2018 | 622.04M |
| December 31, 2017 | 628.37M |
| September 30, 2017 | 606.09M |
| June 30, 2017 | 605.74M |
| March 31, 2017 | 599.96M |
| December 31, 2016 | 391.47M |
| September 30, 2016 | 381.15M |
| June 30, 2016 | 400.70M |
| March 31, 2016 | 391.21M |
| December 31, 2015 | 389.62M |
| September 30, 2015 | 368.99M |
| June 30, 2015 | 354.99M |
| March 31, 2015 | 335.03M |
| December 31, 2014 | 326.07M |
| September 30, 2014 | 305.39M |
| June 30, 2014 | 292.08M |
| March 31, 2014 | 163.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Zimmer Biomet Holdings, Inc. | 22.80B |
| Liquidia Corp. | 521.92M |
| Johnson & Johnson | 201.06B |
| Merck & Co., Inc. | 129.80B |
| ANI Pharmaceuticals, Inc. | 1.494B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 572.00M |
| Shareholders Equity (Quarterly) | 671.98M |
| Debt to Equity Ratio | 0.6133 |
| Current Ratio | 5.042 |
| Net Debt Paydown Yield | 4.44% |